Zimmer Biomet Holdings, Inc. (NYSE:ZBH) was a big mover last session, as the company saw its shares rise more than 6% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This breaks the recent trend of the company, as the stock is now trading above the volatile price range of $112.18 to $117.10 in the past one-month time frame.
The upside was driven by the passage of the tax reform bill, which proposes to lower the maximum corporate tax.
The company has seen one negative estimate revisions in the past one month, while its Zacks Consensus Estimate has remained unchanged, suggesting there may be trouble down the road. So make sure to keep an eye on this stock going forward, to see if this recent move higher can last.
Zimmer Biomet currently has a Zacks Rank #4 (Sell), while its Earnings ESP is positive.
A better-ranked stock in the Medical - Products industry is Bio-Rad Laboratories, Inc. (NYSE:BIO) , which currently sports a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.
Is ZBH going up? Or down? Predict to see what others think: Up or Down
5 Medical Stocks to Buy Now
Zacks names 5 companies poised to ride a medical breakthrough that is targeting cures for leukemia, AIDS, muscular dystrophy, hemophilia, and other conditions.
New products in this field are already generating substantial revenue and even more wondrous treatments are in the pipeline. Early investors could realize exceptional profits.
Click here to see the 5 stocks >>
Bio-Rad Laboratories, Inc. (BIO): Free Stock Analysis Report
Zimmer Biomet Holdings, Inc. (ZBH): Free Stock Analysis Report
Original post
Zacks Investment Research